HC Wainwright & Co. Maintains Buy on Aura Biosciences, Lowers Price Target to $18

Benzinga · 2d ago
HC Wainwright & Co. analyst Andres Y. Maldonado maintains Aura Biosciences (NASDAQ:AURA) with a Buy and lowers the price target from $24 to $18.